Post by Bristol Myers Squibb on X
Bristol Myers Squibb@bmsnews
X#MEDIA: Announcing the final analysis of OS from the CheckMate -816 trial evaluating our #immunotherapy used in combination with chemotherapy regimen as neoadjuvant treatment of resectable non-small cell #lungcancer. #NSCLC #LCSM t.co

42 likes13 repliesPosted Feb 19, 2025